CN103911448B - The genetic chip of detection traumatic injury analgesic plaster effect and application thereof - Google Patents

The genetic chip of detection traumatic injury analgesic plaster effect and application thereof Download PDF

Info

Publication number
CN103911448B
CN103911448B CN201410132129.8A CN201410132129A CN103911448B CN 103911448 B CN103911448 B CN 103911448B CN 201410132129 A CN201410132129 A CN 201410132129A CN 103911448 B CN103911448 B CN 103911448B
Authority
CN
China
Prior art keywords
correlated
traumatic injury
interleukin
detection
activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410132129.8A
Other languages
Chinese (zh)
Other versions
CN103911448A (en
Inventor
邓慧敏
杨威
黄杰伟
符美燕
肖百全
郭秋平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baiyunshan Hejigong Pharmaceutical Factory Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Original Assignee
Baiyunshan Hejigong Pharmaceutical Factory Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baiyunshan Hejigong Pharmaceutical Factory Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd filed Critical Baiyunshan Hejigong Pharmaceutical Factory Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Priority to CN201410132129.8A priority Critical patent/CN103911448B/en
Publication of CN103911448A publication Critical patent/CN103911448A/en
Application granted granted Critical
Publication of CN103911448B publication Critical patent/CN103911448B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Abstract

The genetic chip of detection traumatic injury analgesic plaster effect and application thereof, have a probe that RNA, cRNA or the cDNA produced for following gene carries out detecting: 1) inflammatory reaction relevant, 2) wound response is relevant, 3) immune response is relevant, 4) defense response is relevant, 5) angiogenic growth is relevant, 6) energy is correlated with.The genetic chip of the present invention, it is possible to perform well in detecting drug effect and the mechanism of action of traumatic injury analgesic cream.

Description

The genetic chip of detection traumatic injury analgesic plaster effect and application thereof
Technical field
The present invention relates to detect genetic chip and the application thereof of traumatic injury analgesic plaster effect.
Background technology
At present, the medicine effect of China's traumatic injury analgesic cream series products and the research of mechanism of action are nearly at starting In the stage, document is based on clinical observation on the therapeutic effect, as made the observation of curative effect of blood-circulation and removing blood stasis ointment, injuries from falls as well cream by oneself The clinical observation etc. for the treatment of acute and closed soft tissue injury.701 traumatic injury analgesic cream also do not carry out deep mechanism Research.At present, only 1, the document of report, i.e. about the Study of Marketing Tactics of 701 traumatic injury analgesic cream, not Relate to effect and Mechanism Study.
Summary of the invention
Present invention provide for detecting genetic chip and the application thereof of traumatic injury analgesic plaster effect, it is possible to well Disclose mechanism of action and the principle of traumatic injury analgesic cream.
For solving the problems referred to above, the technical solution adopted in the present invention is as follows:
The genetic chip of detection traumatic injury analgesic plaster effect, it is characterised in that:
Described genetic chip has the spy that RNA, cRNA or the cDNA produced for following gene carries out detecting Pin:
1) inflammatory reaction is correlated with: CC CCL11, II type trans-activator, interleukin-11 β, blood Platelet selects element, p75TNFR;
2) wound response is correlated with: CC CCL11, II type trans-activator, hypoxia inducible factor 1 α, interleukin-11 β, palatelet-selectin, p75TNFR;
3) immune response is correlated with: CC CCL11, II type trans-activator, interleukin-11 β, phosphorus Fat is creeped enzyme 1, p75TNFR;
4) defense response is correlated with: CC CCL11, II type trans-activator, hypoxia inducible factor 1 α, interleukin-11 β, palatelet-selectin, p75TNFR;
5) angiogenic growth is correlated with: Kruppel like factor 5, hypoxia-inducible factor-1 alpha, interleukin-11 β, blood platelet Select element;
6) energy is correlated with: Sarcoplasmic reticulum calcium ion ATP enzyme 2, II type trans-activator, hexokinase 3, Cardiac muscle β-myosin heavy chain 7B, muscle phospho fructokinase, blood platelet class phosphofructokinase, runt are correlated with Transcription factor 1, Sulfotransferase 1A1.
A kind of method utilizing genechip detection traumatic injury analgesic plaster to imitate, in turn includes the following steps:
A: take a rabbit, then uses the weight method of falling to prepare soft tissue injury model: selection weight is 1kg Weight, freely fall at vertical direction 20cm of rabbit back leg root soft tissue, it is thus achieved that soft tissue injury Model;Step B: behind 24 hours that step A completes, measures the scoring of rabbit soft tissue injury, wherein measures The instrument that valve uses bitterly is tenderness instrument, and red and swollen scope is not less than 1 square centimeter;Step C: in the damage of rabbit Traumatic injury analgesic cream is sticked at position;Step D: extract RNA at the damage location of rabbit, standby;Step E: Select DNA chip, with step D extract RNA carry out in situ hybridization, wherein said DNA chip have as Under RNA, cRNA or cDNA of producing for following gene carry out the probe that detects: 1) inflammatory reaction is correlated with: CC CCL11 (chemokine (C-C motif) ligand 11), II type trans-activator (class II transactivator), interleukin-11 β (interleukin-1 beta), palatelet-selectin (selectin, platelet), P75TNFR (tumor necrosis factor receptor superfamily, member 1B);2) wound response is correlated with: CC CCL11 (chemokine (C-C motif) ligand 11), II type trans-activator (class II transactivator), hypoxia-inducible factor-1 alpha (hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription Factor)), interleukin-11 β (interleukin-1 beta), palatelet-selectin (selectin, platelet), tumour Mecrosis factor receptors superfamily member 1B (tumor necrosis factor receptor superfamily, member 1B);3) immune response is correlated with: CC CCL11 (chemokine (C-C motif) ligand 11), II type trans-activator (class II transactivator), interleukin-11 β (interleukin-1 beta), phosphatide Creep enzyme 1 (phospholipid scramblase 1), p75TNFR (tumor necrosis factor receptor superfamily,member 1B);4) defense response is correlated with: CC chemotactic factor (CF) Ligand 11 (chemokine (C-C motif) ligand 11), II type trans-activator (class II Transactivator), hypoxia-inducible factor-1 alpha (hypoxia-inducible factor 1, alpha subunit (basic Helix-loop-helix transcription factor)), interleukin-11 β (interleukin-1 beta), blood platelet select Element (selectin, platelet), p75TNFR (tumor necrosis factor receptor superfamily,member 1B);5) angiogenic growth is correlated with: Kruppel like factor 5 (Kruppel-like Factor 5), hypoxia-inducible factor-1 alpha (hypoxia-inducible factor 1, alpha subunit (basic Helix-loop-helix transcription factor)), interleukin-11 β (interleukin-1 beta), blood platelet select Element (selectin, platelet);6) energy is correlated with: Sarcoplasmic reticulum calcium ion ATP enzyme 2 (sacroplasmic reticulum Ca2+-ATPase 2), II type trans-activator (class II transactivator), hexokinase 3 (hexokinase 3), cardiac muscle β-myosin heavy chain 7B (myosin, heavy chain 7B, cardiac muscle, Beta), muscle phospho fructokinase (phosphofructokinase, muscle), blood platelet class phosphofructose swash Enzyme (phosphofructokinase, platelet), runt associated transcription factor 1 (runt-related transcription Factor 1), Sulfotransferase 1A1 (sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1);Step F: use gene chip scanning instrument to be scanned, obtain scanning signal and data, After signal and data separate Quantile algorithm are normalized.
In the present invention, preferred scheme is that described F step is: utilize Agilent Microarray Scanner (Cat#G2565CA, Agilent technologies, Santa Clara, CA, US) is scanned;Wherein scanner Software design patterns is: Dye channel:Green, Scan resolution=5 μm, PMT 100%, 10%, 16bit; Then with Feature Extraction software 10.7 (Agilent technologies, Santa Clara, CA, US) Software reads data and signal;Finally use Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US) software is normalized, and algorithm used is Quantile.
In the present invention, what Ji metric system pharmaceutical factory of the preferred Baiyunshan Pharmaceutics Stock-sharing Co., Ltd., Guangzhou City of traumatic injury analgesic cream is (wide What Ji metric system pharmaceutical factory, White Cloud Mountain, state Pharmacy stock Co., Ltd White Cloud Mountain) " the 701 traumatic injury analgesic cream " that produces.
Compared with traditional traumatic injury analgesic cream Composition analyzed, the invention have the advantage that the present invention utilizes gene core Chip technology, uses new zealand rabbit as the acquisition object of soft tissue injury model, then utilizes instrument to carry out Scanning, detection, data process, and have understood mechanism of action and effect of traumatic injury analgesic cream according to data, with biography The employing naked eyes of system or microscope are observed, and have the most progressive;This detection method is quick, easy simultaneously, The experiment parameter filtered out through applicant's great many of experiments and probe combinations, it is possible to testing result is more as the criterion Really.
Below in conjunction with the accompanying drawings and the present invention is described in further detail by detailed description of the invention.
Accompanying drawing
DNA Microarray Scanning figure used by Fig. 1: embodiment 1;
Box traction substation measured by Fig. 2: embodiment 1;
Scatter diagram measured by Fig. 3: embodiment 1;
Volcano figure measured by Fig. 4: embodiment 1;
Detailed description of the invention
Embodiment 1
A kind of method utilizing genechip detection traumatic injury analgesic plaster to imitate, in turn includes the following steps:
A: take a rabbit, then uses the weight method of falling to prepare soft tissue injury model: selection weight is 1kg Weight, freely fall at vertical direction 20cm of rabbit back leg root soft tissue, it is thus achieved that soft tissue injury Model;Step B: behind 24 hours that step A completes, measures the scoring of rabbit soft tissue injury, wherein measures The instrument that valve uses bitterly is tenderness instrument, and red and swollen scope is not less than 1 square centimeter;Step C: in the damage of rabbit Traumatic injury analgesic cream is sticked at position, and wherein traumatic injury analgesic cream is how Baiyunshan Pharmaceutics Stock-sharing Co., Ltd., Guangzhou City helps public affairs Pharmaceutical factory (i.e. Baiyunshan Hejigong Medicine Factory of Guangzhou Baiyunshan Pharmaceutical Co., Ltd.) produce " 701 fall Beat analgesia ointment ";Step D: extract RNA at the damage location of rabbit, standby;Step E: select DNA Chip, the RNA extracted with step D carries out in situ hybridization, and wherein said DNA chip has following for such as RNA, cRNA or cDNA that lower gene produces carries out the probe that detects: 1) inflammatory reaction is correlated with: chemokine (C-C motif)ligand 11、class II transactivator、interleukin-1 beta、selectin,platelet、 tumor necrosis factor receptor superfamily,member 1B;2) wound response is correlated with: chemokine(C-C motif)ligand 11、class II transactivator、hypoxia-inducible factor 1, alpha subunit(basic helix-loop-helix transcription factor)interleukin-1 beta、selectin, platelet、tumor necrosis factor receptor superfamily,member 1B;3) immune response is correlated with: chemokine(C-C motif)ligand 11、class II transactivator、interleukin-1 beta、 phospholipid scramblase 1、tumor necrosis factor receptor superfamily,member 1B; 4) defense response be correlated with: chemokine (C-C motif) ligand 11, class II transactivator, hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;5) angiogenic growth is correlated with: Kruppel-like factor 5, hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet;6) energy is correlated with: sacroplasmic reticulum Ca2+-ATPase 2、class II transactivator、hexokinase 3、myosin,heavy chain 7B,cardiac muscle,beta、 phosphofructokinase,muscle、phosphofructokinase,platelet、runt-related transcription factor 1、sulfotransferase family,cytosolic,1A,phenol-preferring,member 1;Step F: Utilize Agilent Microarray Scanner (Cat#G2565CA, Agilent technologies, Santa Clara, CA, US) it is scanned;Wherein scanner software is set to: Dye channel:Green, Scan Resolution=5 μm, PMT 100%, 10%, 16bit;Then with Feature Extraction software 10.7 (Agilent technologies, Santa Clara, CA, US) software reads data and signal;Finally use Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US) software is normalized Processing, algorithm used is Quantile.
Embodiment 2
A kind of method utilizing genechip detection traumatic injury analgesic plaster to imitate, in turn includes the following steps:
A: take a rabbit, then uses the weight method of falling to prepare soft tissue injury model: selection weight is 1kg Weight, freely fall at vertical direction 20cm of rabbit back leg root soft tissue, it is thus achieved that soft tissue injury Model;Step B: behind 24 hours that step A completes, measures the scoring of rabbit soft tissue injury, wherein measures The instrument that valve uses bitterly is tenderness instrument, and red and swollen scope is not less than 1 square centimeter;Step C: in the damage of rabbit Traumatic injury analgesic cream is sticked at position, and wherein traumatic injury analgesic cream is how Baiyunshan Pharmaceutics Stock-sharing Co., Ltd., Guangzhou City helps public affairs Pharmaceutical factory (i.e. Baiyunshan Hejigong Medicine Factory of Guangzhou Baiyunshan Pharmaceutical Co., Ltd.) produce " 701 fall Beat analgesia ointment ";Step D: extract RNA at the damage location of rabbit, standby;Step E: carry with step D The RNA taken carries out in situ hybridization, wherein said DNA chip have produce for following gene as follows RNA, CRNA or cDNA carries out the probe detected: 1) inflammatory reaction is correlated with: chemokine (C-C motif) ligand 11、class II transactivator、interleukin-1 beta、selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;2) wound response is correlated with: chemokine (C-C motif) ligand 11、class II transactivator、hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;3) immune response is correlated with: interleukin-1 beta、phospholipid scramblase 1、tumor necrosis factor receptor superfamily,member 1B、Csf2、Tnfrsf6;4) defense response is correlated with: chemokine (C-C motif) ligand 11, class II transactivator、hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;5) angiogenic growth is correlated with: Kruppel-like factor 5, hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet;6) energy is correlated with: sacroplasmic reticulum Ca2+-ATPase 2、class II transactivator、hexokinase 3、myosin,heavy chain 7B,cardiac muscle,beta、phosphofructokinase,muscle、phosphofructokinase,platelet、 runt-related transcription factor 1、sulfotransferase family,cytosolic,1A, phenol-preferring,member 1;Step F: utilize Agilent Microarray Scanner (Cat#G2565CA, Agilent technologies, Santa Clara, CA, US) is scanned;Wherein scanner Software design patterns is: Dye channel:Green, Scan resolution=5 μm, PMT 90%, 10%, 15bit;So Soft with Feature Extraction software 10.7 (Agilent technologies, Santa Clara, CA, US) afterwards Part reads data and signal;Finally use Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US) software is normalized, and algorithm used is Quantile.
Embodiment 3
A kind of method utilizing genechip detection traumatic injury analgesic plaster to imitate, in turn includes the following steps:
A: take a rabbit, then uses the weight method of falling to prepare soft tissue injury model: selection weight is 1kg Weight, freely fall at vertical direction 20cm of rabbit back leg root soft tissue, it is thus achieved that soft tissue injury Model;Step B: behind 24 hours that step A completes, measures the scoring of rabbit soft tissue injury, wherein measures The instrument that valve uses bitterly is tenderness instrument, and red and swollen scope is not less than 1 square centimeter;Step C: in the damage of rabbit Traumatic injury analgesic cream is sticked at position, and wherein traumatic injury analgesic cream is how Baiyunshan Pharmaceutics Stock-sharing Co., Ltd., Guangzhou City helps public affairs Pharmaceutical factory (i.e. Baiyunshan Hejigong Medicine Factory of Guangzhou Baiyunshan Pharmaceutical Co., Ltd.) produce " 701 fall Beat analgesia ointment ";Step D: extract RNA at the damage location of rabbit, standby;Step E:1) inflammation is anti- Should be correlated with: chemokine (C-C motif) ligand 11, class II transactivator, interleukin-1 beta, selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;2) wound Response is correlated with: Vegefa, Gnrh2, hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;3) immune response is correlated with: chemokine (C-C motif)ligand 11、RT1-Bb、interleukin-1 beta、phospholipid scramblase 1、tumor necrosis factor receptor superfamily,member 1B;4) defense response is correlated with: chemokine (C-C motif)ligand 11、class II transactivator、hypoxia-inducible factor 1,alpha subunit (basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet、 tumor necrosis factor receptor superfamily,member 1B;5) angiogenic growth is correlated with: Kruppel-like factor 5、hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet;6) energy Amount is relevant: sacroplasmic reticulum Ca2+-ATPase 2、class II transactivator、hexokinase 3、myosin,heavy chain 7B,cardiac muscle,beta、phosphofructokinase,muscle、 phosphofructokinase,platelet、runt-related transcription factor 1、sulfotransferase family,cytosolic,1A,phenol-preferring,member 1;Step F: utilize Agilent Microarray Scanner (Cat#G2565CA, Agilent technologies, Santa Clara, CA, US) is scanned;Its Middle scanner software is set to: Dye channel:Green, Scan resolution=5 μm, PMT 95%, 10%, 18bit;Then with Feature Extraction software 10.7 (Agilent technologies, Santa Clara, CA, US) software reads data and signal;Finally use Gene Spring Software 11.0 (Agilent Technologies, Santa Clara, CA, US) software is normalized, and algorithm used is Quantile.
Embodiment 4
A kind of method utilizing genechip detection traumatic injury analgesic plaster to imitate, in turn includes the following steps: A: take One rabbit, then uses the weight method of falling to prepare soft tissue injury model: selecting weight is the weight of 1kg, from Freely fall at vertical direction 30cm of rabbit back leg root soft tissue, it is thus achieved that soft tissue injury model;Step B: Behind 24 hours that step A completes, measure the scoring of rabbit soft tissue injury, wherein measure the instrument that pain valve uses For tenderness instrument, red and swollen scope is not less than 1 square centimeter;Step C: the damage location rabbit sticks Die Da town Cream bitterly, wherein traumatic injury analgesic cream is what Ji (i.e. Guangzhou, metric system pharmaceutical factory of Baiyunshan Pharmaceutics Stock-sharing Co., Ltd., Guangzhou City What Ji metric system pharmaceutical factory, White Cloud Mountain Pharmacy stock Co., Ltd White Cloud Mountain) " the 701 traumatic injury analgesic cream " that produces;Step Rapid D: extract RNA at the damage location of rabbit, standby;Step E: the RNA extracted with step D is carried out In situ hybridization, wherein said DNA chip have RNA, the cRNA produced for following gene as follows or CDNA carries out the probe detected: 1) inflammatory reaction is correlated with: chemokine (C-C motif) ligand 11, class II transactivator、interleukin-1 beta、selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;2) wound response is correlated with: Lcn2, Bag3, class II transactivator, hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;3) immune response be correlated with: chemokine (C-C motif) ligand 11, Spn, F3、Ccl5、interleukin-1 beta、phospholipid scramblase 1、tumor necrosis factor receptor superfamily,member 1B;4) defense response is correlated with: chemokine (C-C motif) ligand 11、class II transactivator、hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet、tumor necrosis factor receptor superfamily,member 1B;5) angiogenic growth is correlated with: Kruppel-like factor 5、hypoxia-inducible factor 1,alpha subunit(basic helix-loop-helix transcription factor)、interleukin-1 beta、selectin,platelet;6) energy is correlated with: sacroplasmic reticulum Ca2+-ATPase 2、class II transactivator、myosin,heavy chain 7B,cardiac muscle,beta、phosphofructokinase,muscle、phosphofructokinase,platelet、 runt-related transcription factor 1、sulfotransferase family,cytosolic,1A, phenol-preferring,member 1;Step F: utilize Agilent Microarray Scanner (Cat#G2565CA, Agilent technologies, Santa Clara, CA, US) is scanned;Wherein scanner Software design patterns is: Dye channel:Green, Scan resolution=5 μm, PMT 100%, 8%, 14bit;So Soft with Feature Extraction software 10.7 (Agilent technologies, Santa Clara, CA, US) afterwards Part reads data and signal;Finally use Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US) software is normalized, and algorithm used is Quantile.
Embodiment 5
According to the detection method of embodiment 1, detect that the target gene of 701 traumatic injury analgesic cream is 302, rise Gene has 193, and the gene of downward has 109.Target gene carries out GO analyze and show, with inflammation and stress Relevant down regulation of gene expression, the gene expression of regeneration and multicellular tissue growth is raised.Additionally, capilary Form gene and ossified gene etc. to raise.The Pathway analysis result of target gene is shown, the letter of differential gene Number path is mainly relevant, in addition with the inflammatory factor path such as IL-1R signal path, leukocyte adhesion signal path Also have φt cell receptor signal path, MAPK signal path, nucleic acid acceptor toxicant metabolism path etc. relevant, this Path is relevant with the action pathway of medicine.
1) chip differential gene data (701 compared with model group)
2) chip differential gene data (model group is compared with negative control group)
The ideograph (Box-whisker Plot) of the box traction substation of Fig. 2 GeneSpring Software on Drawing, is to utilize number Five statistics according to: minimum of a value, first quartile (25%), median (50%), the 3rd Quartile (75%) and maximum describe a kind of method of data, and it can also find out that data are roughly The information such as no have symmetry, point spread of distribution, are especially possible for the comparison to several samples.
Fig. 3 illustrates: the initial data of single Fluorescence chip, through standardization, is converted into log with 2 as the end Logarithm after, in a two-dimensional direct angle coordinate system plane, draw scatter diagram (scatter plot).Chip data Scatter diagram be usually used in assessing two groups of data overall distribution central tendencies.In scatter diagram, each point represents chip
On probe points, this position in two dimensional surface is determined by its X-axis coordinate and Y-axis coordinate: X Axle: this signal value after sample chip Plays.Y-axis: this point is at comparison chip Plays Later signal value.Fall the point on y=x straight line (neutrality line on figure) in the graphic, and it represents this and visits Pin mark signal value difference Fold Change=1 in two chips falls in the graphic outside the line of 45 °, bit line both sides Point, it represents this probe points signal value difference Fold Change > 2 in two chips;A district: 2 times Up-regulated gene, B district: 2 times of down-regulated genes.
Fig. 4 illustrates: jointly draw volcano with analyzing the P-value value obtained with two factors of Fold change value Plot volcano figure, for the significant difference of two groups of sample datas of display.In the figure of volcano, one of them is sat Mark shows the negative log of p-value evolved by T-test, and another one coordinate shows that two conditions compare Fiducial value after lower log2 conversion.X-axis: Log2 (Fold Change);Y-axis :-Log10 (p-value);X Axle parallel lines: p-value=0.05;Y-axis parallel lines: Fold Change=2;Dark colour part: p-value < 0.05 Fold Change >=2 differential genes.
Rabbit damage model genetic chip result of study shows that model group is 414 with the differential gene of control group, The gene raised has 346, and the gene of downward has 68.The GO of differential gene analyzes and shows in immunological regulation The gene (leukocyte recruitment and adhesion, the cytotoxicity of leucocyte mediation) of functional gene and inflammation-related Increase Deng expression, the gene expression of stress reaction increases, gene of taking action, multicellular tissue growth hormone gene are expressed Reduce.
Embodiment 6
Detection method to embodiment 1-4 carries out Stability and veracity experiment respectively, and each embodiment carries out five Secondary experiment, then evaluates its Stability and veracity, and wherein accuracy experimental evaluation data are five experiments Average, stability experiment utilizes the standard deviation of experimental data to be evaluated, its result such as following table:
Accuracy (mean value) Stability (standard deviation)
Embodiment 1 90% 5.2%
Embodiment 2 83% 10.1%
Embodiment 3 85% 9.5%
Embodiment 4 86% 11.3%
As can be seen from the above table, detection method of the present invention, Stability and veracity is higher, energy Enough good drug effect and mechanism to traumatic injury analgesic cream is evaluated.
Above-mentioned embodiment is only the preferred embodiment of the present invention, it is impossible to limit present invention protection with this Scope, the change of any unsubstantiality that those skilled in the art is done on the basis of the present invention and replacement Belong to scope of the present invention.

Claims (3)

1. the genetic chip of detection traumatic injury analgesic plaster effect, it is characterised in that:
Described genetic chip has the spy that RNA, cRNA or the cDNA produced for following gene carries out detecting Pin:
1) inflammatory reaction is correlated with: CC CCL11, II type trans-activator, interleukin-11 β, blood Platelet selects element, p75TNFR;
2) wound response is correlated with: CC CCL11, II type trans-activator, hypoxia inducible factor 1 α, interleukin-11 β, palatelet-selectin, p75TNFR;
3) immune response is correlated with: CC CCL11, II type trans-activator, interleukin-11 β, phosphorus Fat is creeped enzyme 1, p75TNFR;
4) defense response is correlated with: CC CCL11, II type trans-activator, hypoxia inducible factor 1 α, interleukin-11 β, palatelet-selectin, p75TNFR;
5) angiogenic growth is correlated with: Kruppel like factor 5, hypoxia-inducible factor-1 alpha, interleukin-11 β, blood platelet Select element;
6) energy is correlated with: Sarcoplasmic reticulum calcium ion ATP enzyme 2, II type trans-activator, hexokinase 3, Cardiac muscle β-myosin heavy chain 7B, muscle phospho fructokinase, blood platelet class phosphofructokinase, runt are correlated with Transcription factor 1, Sulfotransferase 1A1.
The genetic chip of detection traumatic injury analgesic plaster the most according to claim 1 effect, it is characterised in that: Described traumatic injury analgesic cream is the traumatic injury analgesic what Ji metric system pharmaceutical factory of Baiyunshan Pharmaceutics Stock-sharing Co., Ltd., Guangzhou City produces Cream.
The genetic chip of detection traumatic injury analgesic plaster the most according to claim 1 effect, it falls in detection beats Application in analgesia ointment drug effect.
CN201410132129.8A 2014-04-02 2014-04-02 The genetic chip of detection traumatic injury analgesic plaster effect and application thereof Active CN103911448B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410132129.8A CN103911448B (en) 2014-04-02 2014-04-02 The genetic chip of detection traumatic injury analgesic plaster effect and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410132129.8A CN103911448B (en) 2014-04-02 2014-04-02 The genetic chip of detection traumatic injury analgesic plaster effect and application thereof

Publications (2)

Publication Number Publication Date
CN103911448A CN103911448A (en) 2014-07-09
CN103911448B true CN103911448B (en) 2016-08-17

Family

ID=51037450

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410132129.8A Active CN103911448B (en) 2014-04-02 2014-04-02 The genetic chip of detection traumatic injury analgesic plaster effect and application thereof

Country Status (1)

Country Link
CN (1) CN103911448B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105891376A (en) * 2016-06-17 2016-08-24 广州白云山医药集团股份有限公司白云山何济公制药厂 Quality standard for Dieda analgesic ointment and testing method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101580881B (en) * 2008-05-09 2012-12-19 北京农学院 Gene chip for evaluating summer fever and effect of traditional Chinese medicine

Also Published As

Publication number Publication date
CN103911448A (en) 2014-07-09

Similar Documents

Publication Publication Date Title
Zhang et al. Prospects of using DNA barcoding for species identification and evaluation of the accuracy of sequence databases for ticks (Acari: Ixodida)
Manarolla et al. Molecular biological characterization of avian poxvirus strains isolated from different avian species
CN105574361A (en) Method for detecting variation of copy numbers of genomes
HRP20220045T1 (en) Method for determining the fraction of cell-free fetal nucleic acids in a peripheral blood sample from a pregnant woman and use thereof
Asadollahpour Nanaei et al. Genetic diversity and signatures of selection for heat tolerance and immune response in Iranian native chickens
HRP20220296T1 (en) Resolving genome fractions using polymorphism counts
JP2013535215A5 (en)
CN102732520B (en) The preparation method of the serum miRNAs that a kind of active tuberculosis is sick special
Gao et al. A new species in the genus Nomocharis Franchet (Liliaceae): evidence that brings the genus Nomocharis into Lilium
CN108064272A (en) Biomarker for rheumatoid arthritis and application thereof
Wostl et al. Taxonomic status of the Sumatran pitviper Trimeresurus (Popeia) toba David, Petri, Vogel & Doria, 2009 (Squamata: Viperidae) and other Sunda shelf species of the subgenus Popeia
CN109295230A (en) A method of the polygene combined abrupt climatic change based on ctDNA assesses tumour dynamic change
CN106636342A (en) EST-SSR marker primer group developed on basis of sequence of transcriptome of ligusticum wallichii, and acquisition method and application of EST-SSR marker primer group
CN104673902A (en) SNP molecular marker related to breast muscle weight and breast muscle percentage of chicken and application of SNP molecular marker
Trejo-Huitrón et al. Morphological characterization and first molecular identification of the eleven Eimeria species that infect sheep from Mexico
Liebhart et al. In-situ hybridization for the detection and identification of Histomonas meleagridis in tissues
CN103911448B (en) The genetic chip of detection traumatic injury analgesic plaster effect and application thereof
Silva et al. Morphological and molecular evidence for two new species of Tetragonopterus (Characiformes: Characidae) from central Brazil
CN103757709A (en) Capture of breast cancer related genes, and preparation method and application of probes
Smith et al. Mapping molecular gene signatures mediated by SARS-COV-2 and large-scale and genome-wide transcriptomics comparative analysis among respiratory viruses of medical importance
CN101967479A (en) Molecular marker related to post-weight of chicken and application thereof
CN114657267B (en) Detection method and application of yak MICALL2 gene CNV marker
CN105177130B (en) It is used for assessing the mark of aids patient generation immune reconstitution inflammatory syndrome
CN102181536A (en) Primer composition, kit and method for detecting mutation of exon 19 of human EGFR gene
CN112501280B (en) High-sensitivity detection method for hydatid cyst based on high-throughput sequencing

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: The new street in Baiyun District of Guangzhou City, Guangdong Province, Xiao Gang No. 52 510000

Applicant after: BAIYUNSHAN HEJIGONG PHARMACEUTICAL FACTORY, GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD.

Address before: The new street in Baiyun District of Guangzhou City, Guangdong Province, Xiao Gang No. 52 510000

Applicant before: BAIYUNSHAN HEJIGONG PHARMACEUTICAL FACTORY, GUANGZHOU BAIYUNSHAN PHARMACEUTICAL CO., LTD.

COR Change of bibliographic data
C14 Grant of patent or utility model
GR01 Patent grant